Health & Biotech
EZZ works to catch e-commerce Southeast Asia growth wave
Health & Biotech
Dr Boreham’s Crucible: Will Suda’s rebirth under Paul Hopper be another mist opportunity?
Health & Biotech
ASX Health Stocks: Althea to start selling medicinal cannabis in Ireland
Health & Biotech
Weed Week: Woody Harrelson opens weed dispensary and Byron Bay could be home to a cannabis resort
Health & Biotech
ASX Health Stocks: Cannabis play Little Green Pharma signs $7.5m German supply deal
Health & Biotech
ASX Health Stocks: Imugene begins Phase 1 trial of its cancer-fighting virus
Health & Biotech
Nutritional Growth Solutions appoints two industry heavyweights to spearhead regional expansion
Health & Biotech
Shares in Incannex jump 11% after positive US FDA meet over sleep apnoea drug
Health & Biotech
Nanollose enters Paradise with forest-friendly Nullarbor fibre collab
Health & Biotech
PharmAust inks deal with Radium Capital to bag up-front R&D tax claim
Health & Biotech
ASX Health Stocks: Nyrada gets closer to European patent, and HOPE for Zelira’s autism tincture
Health & Biotech
CRITERION: Are the thrills worth the spills on the small cap rollercoaster right now? Maybe…
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.